Relationship between immune cells and the development of chronic lung allograft dysfunction

Area of Science:

• Immunology
• Transplantation Science
• Pathophysiology

Background:

• Chronic lung allograft dysfunction (CLAD) significantly impacts long-term survival and quality of life for lung transplant recipients (LTRs).
• The complex pathophysiology and irreversible nature of CLAD present challenges for effective clinical treatments.
• Current immunotherapies only manage CLAD progression, highlighting the need for deeper understanding and novel therapeutic approaches.

Purpose of the Study:

• To review the immunological mechanisms underlying chronic lung allograft dysfunction (CLAD).
• To analyze the role of immune cell subsets in the development and progression of CLAD post-lung transplantation.
• To consolidate recent advancements in understanding the immune microenvironment in CLAD.

Main Methods:

• Literature review focusing on immunological responses in lung allografts.
• Analysis of the quantity, subtype, and characteristics of effector immune cells.
• Examination of immune cell involvement in both peripheral and transplanted lungs.

Main Results:

• Innate and adaptive immune cells, including natural killer cells, eosinophils, neutrophils, macrophages, T cells, and B cells, are critical in CLAD pathogenesis.
• These immune cells contribute through the release of various chemokines and cytokines.
• Alterations in immune cell populations and characteristics within the allograft are central to CLAD development.

Conclusions:

• Understanding the immune microenvironment is paramount for developing effective strategies against CLAD.
• Immune cell dynamics are key drivers of chronic lung allograft dysfunction.
• Further research into immune cell roles can pave the way for targeted CLAD prevention and treatment.